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Abstract 
Background:Hypothyroidism denotes the pathological condition of thyroid hormone deficiency. If untreated, it can 
lead to various adverse health effects. Treatment with thyroxine replacement can mitigate the impact of 
hypothyroidism.Aims & Objectives:To compare the efficacy of morning versus evening dose of levothyroxine and 
To compare the effect of morning versus evening dose of levothyroxine on lipid profile. Materials and methods: 
This observational study was conducted at Saraswati Medical College, Unnao on 76 subjects with hypothyrodism. 
Result:There was no statistically significant difference in the changes in serum TSH and T4 level between patients 
taking evening dose of levothyroxine with those taking morning dose. Serum lipid profile over the 12 and 24 weeks 
period  has not shown any statistically significant difference.Conclusion:Evening schedule of Levothyroxine dose is 
as efficacious as morning dose in terms of thyroid profile and lipid profile. Hence, change of scheduling can be 
effected if needed to achieve better complaince. 
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Introduction  
 
Hypothyroidism denotes the  pathological condition of 
thyroid hormone deficiency. If untreated, it can lead to 
various adverse health effects. As there is a large 
variation in clinical presentation and absence of 
symptom specificity, the definition of hypothyroidism 
is pre-dominantly biochemically determined. Overt or 
clinical primary hypothyroidism can be stated as 
thyroid-stimulating hormone above the referenced 
range and free thyroxine concentrations below the 
referenced range [1]. 
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*Correspondence  
Dr. Rajesh Kumar Manchi 
Assistant Professor ,Dept of Pharmacology, 
Saraswati Medical College, Unnao,UP,India 
 
 
 
 
 
Mild or subclinical hypo-thyroidism,  which is quite 
common, is regarded as a sign of early thyroid failure, 
is defined by TSH concentrations above the referenced 
range and free thyroxine concentrations within the 
normal acceptable range.  
Etiology 
Hypothyroidism is classified as primary (because of  
thyroid hormone deficiency), secondary (due to TSH 
deficiency), tertiary (due to thyrotropin-releasing 
hormone deficiency), and peripheral (extra-thyroidal; 
panel). Central hypothyroidism (including both 
secondary and tertiary) and peripheral hypothyroidism 
are rare and account for less than 1-2% of cases [2]. 
Primary hypothyroidism 
In iodine-sufficient areas based on geography, the 
commonest cause of hypothyroidism is chronic 
autoimmune thyroiditis (also known as Hashimoto’s 
disease). High concentrations of anti-thyroid antibodies 
(predominantly thyroid peroxidase antibodies and anti-
thyroglobulin antibodies) are present in most patients 
with autoimmune thyroiditis. Higher concentrations of 
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thyroid peroxidase antibodies are also detected in about 
12% of the general population. In patients with 
subclinical hypothyroidism, thyroid peroxidase 
antibody measurements help to predict progression to 
overt diseas
. 
The mechanisms underlying autoimmune 
thyroiditis are not known, but both genetic and 
environmental factors are involved. A higher genetic 
risk score—calculated using five genetic variants for 
thyroid peroxidase antibodies identified by genome-
wide association studies—showed a graded association 
with higher TSH concentrations and clinical 
hypothyroidism [3]. 
Central hypothyroidism 
Central hypothyroidism is quite rare It is associated 
with pituitary than hypothalamic disorders .It is defined 
by low or low-to-normal TSH concentrations and a 
disproportionately low concentration of free thyroxine. 
Sometimes, TSH concentration is mildly elevated, 
probably because of decreased bioactivity.Over half of 
central hypothyroidism cases are caused by pituitary 
adenomas.Other causes of central hypothyroidism 
include pituitary or hypothalamic dysfunction due to 
head trauma, pituitary apoplexy, Sheehan’s syndrome, 
surgery, radiotherapy, genetic, and infiltrative disease. 
Several drugs are known to affect the hypothalamic–
pituitary–thyroid axis (panel). 
Peripheral hypothyroidism 
Consumptive hypothyroidism is caused by aberrant 
expression of the deiodinase 3 enzyme (which 
inactivates thyroid hormone) in tumour tissues. It is of 
rare occurance but it can can induce severe 
hypothyroidism. Patients with very rare genetic 
disorders that can  lead to a lower sensitivity to thyroid 
hormones usually have a normal TSH concentrations, 
but can also present with tissue-specific 
hypothyroidism.The treatment modality  in both 
primary and secondary hypothyroidism is thyroxine 
(levothyroxine sodium). It is used as a replacement 
therapy due to its consistency and prolonged duration 
of action. On oral administration, thyroxine is absorbed 
in the stomach and small intestine and is not complete. 
About 80 – 82 % is absorbed, and it is increased when 
taken in before food. Interference with absorption has 
been seen with varios drugs like  iron sulfate, calcium 
preparations, aluminum antacids, activated charcoal et 
al [4]. high fiber diet also shows reduced 
bioavailability of levothyroxine.Traditinally, the 
thyroxine is advised to be taken before food 
.Howevere,i it may be inconvenient to take the drug in 
the morning because of their schedule; For example, 
for Muslims in the month of Ramadan and intake of 
multiple other drugs in the morning due to 
comorbidity. They may request their practitioner to 
prescribe the drug at some other time of the day. The 
results of the study conducted by Visser et al. showed a 
significant improvement in the thyroid hormone profile 
of patients after shifting from morning to the evening 
dose [5].The study showed that changing the timing of 
thyroxine ingestion does not affect quality-of-life 
variables and plasma lipid levels provided it is taken on 
empty stomach. 
Aims and objectives  
 To compare the efficacy of morning versus 
evening dose of levothyroxine 
 To compare the effect of morning versus evening 
dose of levothyroxine on lipid profile 
Materials and methods 
This observational study was be conducted at Saraswati 
Medical College, Unnao.  
STUDY DESIGN: Observational, Interventional study 
STUDY SITE:Department of General Medicine, 
Saraswati Medical College, Unnao. 
SAMPLE SIZE:76 
INCLUSION CRITERIA: 
1. Patients aged 18 years or more 
2. Patients with established hypothyrodism 
3. Patients giving informed consent to participate in 
the study 
EXCLUSION CRITERIA: 
1. Patients aged less than 18 years 
2. Patients with Thyroid cancers 
3. Patients who underwent surgery for thyroid 
4. Patients in ICU 
STUDY PROCEDURE:A detailed history of the 
patient was taken and through clinical examination was 
done.Baseline visit was done at recruitment. Patients 
were asked to come for the second visit after 12 and 24 
weeks .At baseline, blood samples were obtained for 
determination of plasma TSH, T4, and lipid levels. The 
tests were repeated at subsequent visits .The recruited 
patients received levothyroxine sodium once daily. 
Patients in evening group were given levothyroxine 
minimum 2 h after dinner, and those in morning group 
were given the same in the morning minimum half an 
hour before breakfast. Initial dosage was calculated as 
1.6 mcg/kg body weight, and the closest commercially 
available dosage was started. Provision of dose 
adjustment of levothyroxine was kept on 2 weekly 
basis based on serum TSH level. Blood was collected 
for analysis of serum TSH, serum T4 and lipid profile. 
Blood sample was collected in the morning after 12 h 
of overnight fasting. 
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Observation and result 
Table 1 : Demograhic characteristics 
Demographics Morning Group(n = 38) Evening Group(n = 38) P value 
Mean age 44.3 ± 4.7 46.5 ±5.4 0.76 
Male :Female 18:20 19:19 0.65 
BMI (Kg/M
2
) 26.3±2.4 27.2± 3.1 0.43 
 
 
Fig 1:Comparison of thyroid stimulating hormone 
 
Fig 2:Comparison of T4 
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Fig 3:Comparison of serum cholesterol 
 
 
Fig 4:Comparison of serum LDL 
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Fig 5:Comparison of serum LDL 
 
Discussion 
 
Present study noted that there was no statistically 
significant difference in the changes in serum TSH and 
T4 level between patients taking evening dose of 
levothyroxine with those taking morning dose. Serum 
lipid profile over the 12 and 24 weeks period  has not 
shown any statistically significant difference. Primary 
outcomes of this study are consistent with a similar 
study by Rajput et al [6].Analysis  of present study 
suggest a possible option of changing the time of drug 
scheduling from the conventional morning dose to an 
evening dose. It will be beneficial to those who cannot 
remain compliant to  every morning dose .The average 
dose of levothyroxine supplement needed to attain 
euthyroidism and the number of patients who achieved 
euthyroidism were minimally better in the evening 
group, although it was not  statistically significant. 
Reason may be because of  better absorption of drug in 
the evening schedule as to noninterference of food and 
relatively slowed gastric motility [7].Evening 
administration of levothyroxine may be advised for the 
drug to be taken at least 2 h after supper,  so as to have  
hours of empty stomach. Consuming the levothyroxine 
in the morning, 30 minutes before breakfast might not 
result in significant bioavailability. In a study by 
Visser et al. ,they compared the outcome of morning 
with evening dose of administration of levothyroxine 
sodium. This study noted that levothyroxinescheduled 
at night significantly improved thyroid hormone levels, 
but plasma lipids showed no statistically significant 
change as compared to morning dose[5]. These 
observations prove the points of the present study that 
although night administration of levothyroxine is 
statistically may not  be superior to morning schedule, 
it is also may not be inferior to morning dosing as far 
as total dose needed to achieve euthyroidism, number 
of patients achieving euthyroidism at 12 weeks  and 24 
weeks and lipid parameters. Major salient feature of the 
present study is that it involves optimum number of 
patients who are matched compared to all older 
studies.Majority of the subjects  with levothyroxine as 
night  dose in the present study find it more convenient 
and decided to continue with night schedule. Another 
significant issue  was impact of levothyroxine on 
circadian rhythm and nocturnal TSH surge when given 
as night dose .The serum levels of TSH increase in the 
evening, reach a maximum near sleep-onset, and are 
followed by a progressive decrease during the night 
and low values during the day [8,9]. Visser et al. in 
their landmark study observed no change in the 
circadian rhythm of TSH when switching the time of 
levothyroxine ingestion to bedtime. There was no 
statistically significant change in T4, reverse 3,3',5'-
triiodothyronine (rT3), albumin, and thyroxine binding 
globulin serum levels, or in the T3/rT3 ratio. Persani et 
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al. observed that bioactivity of Thyroid stimulating 
harmone has a circadian rythym with less bioactive and 
varied glycosylated TSH molecules secreted during 
night [10,11]. These notings bear important practical 
consequences inpresent study as the timed blood 
sampling for monitoring thyroid profiles can still be 
performed in the morning as per protocol even if the 
patient is scheduled levothyroxine as evening 
dose.Limitations of our study stand that exact interval 
between dinner and levothyroxine ingestion in the 
bedtime-dosing subjects was not documented. Meals 
are also standardised as fatty foods might interfere with 
absorption. 
Conclusion 
Present study concludes that evening schedule of 
Levothyroxine dose is as efficacious as morning dose 
in terms of thyroid profile and lipid profile. Hence, 
change of scheduling can be effected if needed to 
achieve better complaince. 
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